Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Sanofi-Aventis Details Plans for Emerging Markets

This article was originally published in PharmAsia News

Executive Summary

As Big Pharma strives to educate Wall Street on the promise of emerging markets, Sanofi-Aventis has come out swinging: in a statistic-filled July 2 analyst forum, top executives noted they have a bigger market share and more experience than rivals in some of the fastest-growing countries

You may also be interested in...

Chinese Premier Wen Jiabao Allocates Healthcare Investment, But Essential Drug List Delayed Again

SHANGHAI - China's State Council issued additional healthcare reform plans July 8 to detail the goals of the country's ambitious reform plan. However, the release of the long-awaited essential drug list will be delayed to the end of this year, which was expected to be issued by June

South of the Border: Sanofi’s Tailored Approach To Emerging Markets

Sanofi’s recent acquisition of Medley, Brazil’s leading generics manufacturer, reflects its strategy of going local — and generic — in emerging markets.

China Vows To Invest RMB 850 Billion In Healthcare System By 2011

SHANGHAI - China's State Council has approved a three-year plan to implement part of the country's sweeping health system reforms, and plans to invest RMB 850 billion ($124 billion) into the sector by 2011, according to a report published on the Chinese government's official Web site

Related Content




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts